In this article
Rex MD’s current weight-management page focuses on branded Wegovy tablets and includes provider care in its advertised starting price. An alternative comparison should begin with that actual product pathway, rather than assuming the service still matches an older review.
Other programs may charge a separate membership, offer different branded medicines, or discuss compounded preparations. Those options need distinct product and cost comparisons even when they share the same broad weight-loss category.
Compare the exact branded tablet and complete recurring care bill before considering a different medicine or formulation. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.
What to know first
- Compare the exact branded tablet and complete recurring care bill before considering a different medicine or formulation.
- CoreAge Rx is the first listing through a disclosed commercial arrangement.
- Confirm the proposed product, care arrangement, and complete written payment terms.
How this shortlist was selected
CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.
Compare the exact branded tablet and complete recurring care bill before considering a different medicine or formulation. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.
01. CoreAge Rx — featured partner
Our sponsored self-pay listing is a comparison of another care pathway. We have not established that its offer matches Rex MD’s branded tablet; first placement is not a finding of product equivalence.
The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.
The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.
Continue with our CoreAge Rx review and pricing details.
02. Hello Alpha
Lists branded tablet and injectable options through a separate care membership. Ask about the exact prescription, pharmacy cost, and authorization requirements.
Hello Alpha’s weight-loss page advertises Alpha Plus+ at $79 per month. Prescription costs depend on the product, pharmacy, and coverage; the membership price is not a complete GLP-1 medication bill.
Check the exact medicine and indication with the clinician. Membership does not guarantee a prescription, and insurance assistance does not guarantee approval or a refund if a prior authorization is denied.
Check the official Hello Alpha program page for the current offer and conditions. Our Hello Alpha alternatives comparison examines other care models.
03. Maximus
Lists branded tablets alongside compounded preparations and injections. Its mixed pricing blocks make a written product-specific total especially useful.
Maximus lists compounded semaglutide from $116 and tirzepatide from $198 per 28-day supply, alongside a first-month discount tied to a 12-month purchase. Other sections show different price ranges, so the chosen product, term, and complete clinical fees need confirmation.
Compare 28-day supplies over the same period as a calendar-month plan. Ask for the full annual obligation and consultation charges rather than assuming every displayed medication price includes the same care.
Check the official Maximus program page for the current offer and conditions. Our Maximus alternatives comparison examines other care models.
04. Ro
A branded-medication pathway with membership and coverage assistance. Confirm the particular product available through the selected program and the total cost.
Ro lists $39 for the first Body membership month, then $149 on a month-to-month plan, or an advertised monthly equivalent as low as $74 with annual prepayment. The cost of the medication is excluded.
For an insured prescription, Ro describes sending it to a pharmacy; cash-pay routes can differ. Confirm the pharmacy and whether your prescribed product is a manufacturer-labeled medicine. Do not use an old compounded-pricing article to identify the product in a new Ro checkout.
Continue with our Ro review and pricing details.
05. ZipHealth
A branded-treatment comparison with a separate clinical-service fee. Ask whether the desired formulation is available and how often that fee applies.
ZipHealth advertises personalized weight-loss programs from $149 per month plus a $79 clinical-service-and-support fee per treatment. Its medication figures are estimates and depend on the selected product and pharmacy.
Ask how often the $79 fee applies and obtain a complete treatment quote. If arriving from the former Levity service, confirm the new contract and support arrangements instead of assuming the old subscription continues unchanged.
Check the official ZipHealth program page for the current offer and conditions.
06. Strut Health
Relevant only as a different formulation comparison if you are exploring a lozenge. Its compounded buccal product should not be described as the same medicine as the branded tablet.
Strut lists compounded injectable semaglutide at $129 for a monthly vial and a compounded oral buccal lozenge at $199 for a 30-day supply. It says physician consultations and shipping are included, with final pricing determined after assessment.
Compare like routes and exact formulations. A buccal lozenge is not the same product as an approved oral tablet, and evidence about an injection does not establish equivalent results for a lozenge. Check the next automatic-refill date.
Check the official Strut Health program page for the current offer and conditions. Our Strut Health alternatives comparison examines other care models.
The current Rex MD baseline
Rex MD’s current weight-management page advertises Wegovy tablets plus provider care starting at $349 per month. It names multiple tablet strengths and says the offer covers its listed titration strengths; the selected offer still needs confirmation.
The page describes online assessment and a branded Wegovy tablet pathway through Rex MD and NovoCare. Insurance is not required for the advertised offer.
Confirm that your quote is for the branded tablet, the full recurring charge, and the follow-up arrangements. A compounded lozenge, a sublingual preparation, and a branded tablet are not interchangeable products.
The details that decide this comparison
Ask whether the quoted product is the branded Wegovy tablet and whether the price applies to the prescribed strength and later refills.
For a membership-based alternative, add membership to the pharmacy charge. For an insurance pathway, verify medication coverage separately from clinician access.
If considering a compounded lozenge or sublingual product, treat it as a different formulation with different evidence. Similar ingredient names do not make it an interchangeable tablet.
Keep the treatment distinction clear
An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.
Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.
Before you make a change
Tell the clinician whether your main priority is a specific approved product, avoiding injections, a lower total charge, or insurance access. Each priority leads to a different shortlist.
When changing products, follow the receiving clinician’s and pharmacist’s instructions for the new prescription. Keep the original label available so that the comparison is based on what you actually received.
Sources & research notes
Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.
- CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
- CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
- CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
- CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
- CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
- Hello Alpha: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- FDA: Wegovy semaglutide tablets, NDA 218316 approval letterRegulatory source · Checked September 21, 2026
- Maximus: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Weight Loss - Ro Body Membership | RoProvider-published information · Checked September 21, 2026
- Ro - Telehealth for ED, Hair loss, Skincare, Fertility and MoreProvider-published information · Checked September 21, 2026
- ZipHealth: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Strut Health: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Rex MD: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
- FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026
Read our methodology · Commercial disclosure · Request a correction